Skip to content
DataLookout
Menu

NCT06977360

Feasibility, Acceptability and Preliminary Efficacy of the New Iteration of the Innovative Smartphone-based Care Solution for Women With Breast Cancer Undergoing Chemotherapy (iCareBreast+): A Pilot Study Research Proposal

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 11 words
    • Trial completed
    • Site details revised
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Dec 2025 to Oct 31, 2025
    • Start date changed from estimate of Jul 2025 to May 23, 2025
    • Site details revised
    v2
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

The feasibility of research method and Intervention
Timeframe: Throughout data collection period, estimated up to six months or until last subject with last visit completion whichever is later.
The acceptability of intervention
Timeframe: After intervention (two months immediately post intervention)
The impact of psychosocial intervention (iCareBreast+ app) on cancer self-efficacy
Timeframe: Baseline (on enrolment day), and after Intervention (two months immediately post intervention)
The impact of psychosocial Intervention (iCareBreast+ app) on knowledge of breast cancer treatment
Timeframe: Baseline (on enrolment day), and after Intervention (two months immediately post intervention)

Secondary (4)

The impact of psychosocial Intervention (iCareBreast+ app) on anxiety and depression
The impact of psychosocial Intervention (iCareBreast+ app) on cancer related quality of life
The impact of psychosocial Intervention (iCareBreast+ app) on cancer self-efficacy
The impact of psychosocial Intervention (iCareBreast+ app) on satisfaction of oncological care

Arms and interventions

Control GroupExperimental
Intervention GroupExperimental

Other: Routine care, Routine care + iCareBreast+ mobile app

Sites

1 site in 1 country

  • National Cancer Centre, SingaporeSingapore, Singapore